Injectable drug delivery is the introduction of a drug or drugs to a patient with the help of a delivery device such as a needle and syringe. It is essential that the injectable drug delivery is sterile. Sterile injectable drugs are usually formulated in liquid form and they allow the transport of drugs directly into the body through circulating blood, even though they may be designed to transport the drug to a specific part of the body.
Rise in chronic diseases across the world, especially cancer and diabetes; increase in focus of drug manufacturers on research and development of anti-cancer drugs; swift approvals by the FDA in the case of sterile injectables; coupled with short approval timelines for new drug for the treatment of cancer are the key factors boosting demand for sterile injectables in the global market. Manufacture and expansion of sterile injectable drug products are complex and cost-oriented. Manufacturing and handling costs of sterile injectable drugs are comparatively higher than conventional dosage forms as the former needs to be sterilized before or during manufacturing. Furthermore, in the U.S., the FDA has imposed stringent regulations on the facilities and equipment involved in the manufacture of sterile injectable drugs, as these are highly toxic and infectious. Therefore, a high level of quality and care is essential in the manufacture, packaging, storage, and distribution of sterile injectable drugs.
The global sterile injectable drugs market can be segmented based on type of drug, type of device used, application, route of administration, molecule type, and distribution channel. In terms of type of drug, the market can be sub-segmented into monoclonal antibodies, cytokines, peptide hormones, vaccines, peptide antibiotics, insulin, blood factors, immunoglobulin, and others. In terms of type of device used, the market can be further divided into disposable syringes, reusable needles, pre-filled syringes, needle-free injectors, auto-injectors, and pen-needles. Based on application, the sterile injectable drugs market can be segmented into cancer, diabetes, musculoskeletal, CNS, cardiovascular diseases, and infection. The cancer application segment is dominant in the market, as several drugs for the treatment of cancer are currently developed in biologic form. In terms of route of administration, the sterile injectable drugs market can be segmented into intravenous (IV), intramuscular (IM), subcutaneous (SC), intraperitoneal, and others. Based on molecule type, the sterile injectable drugs market can be categorized into small molecules and large molecules. The large molecules segment dominates the market, as there are numerous biologics manufactured as sterile injectable drugs for the treatment of cancer. In terms of distribution channel, the market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
Geographically, the sterile injectable drugs market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America leads the market, followed by Europe. However, the sterile injectable drug market is anticipated to grow rapidly in the emerging countries in Asia Pacific and Latin America, owing to high incidence of chronic diseases such as cancer and diabetes in the countries, coupled with rise in compliance of patients with regard to novel technologies of treatment. Additionally, drug manufacturers are focused on the emerging countries due to swift approvals and lower competition in entering the market in these regions.
Key players in the global sterile injectable drugs market include Baxter International, Inc., Becton, Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Dickinson and Company, Antares Pharma, Inc., Merck & Co., Inc., Johnson & Johnson Services, Inc., Novartis AG, and Nova Nordisk A/S.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.